HLB Panagene, a genetic molecular diagnostics company, announced that it has received export licenses from the Ministry of Food and Drug Safety for two new cancer-related diagnostic kits targeting RET and c-Met, which are gene mutations in non-small cell lung cancer (NSCLC).
 

Please refer to the following website for further details : HLB Panagene Receives Export Licenses for Two Cancer-Related Mutation Test Kits < Health < IT Wellness < 기사본문 - IT Times